Theragenics Corporation Reports Record Revenue for Second Quarter and First Half of 2011

Published: Aug 11, 2011

BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2011.

Back to news